Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Ownership
Insiders

 
 

BridgeBio Pharma LLC Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues140.130.6
            Revenue growth358.4% 
Cost of goods sold183.743.9
Gross profit-43.6-13.3
            Gross margin-31.1%-43.5%
General and administrative43.613.3
EBIT-183.7-43.9
            EBIT margin-131.1%-143.5%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy